Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We examined the effect of tofacitinib induction treatment on Inflammatory Bowel Disease Questionnaire (IBDQ) items in adults with moderate to severe UC. METHODS: Data were pooled f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinsky, Marla C, DiBonaventura, Marco, Fan, Haiyun, Bushmakin, Andrew G, Cappelleri, Joseph C, Maller, Eric, Thorpe, Andrew J, Salese, Leonardo, Panés, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205629/
https://www.ncbi.nlm.nih.gov/pubmed/32794567
http://dx.doi.org/10.1093/ibd/izaa193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205629/
https://www.ncbi.nlm.nih.gov/pubmed/32794567
http://dx.doi.org/10.1093/ibd/izaa193

Ejemplares similares